Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in closed-loop controlled general anesthesia
NCT03009409Phase 1Completed
- Sponsor
- NeuroWave Systems
- Start
- Mar 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of ketamine in Anesthesia (2 arms), sponsored by NeuroWave Systems. Primary endpoint: Controller performance at 1 year. Started Mar 2018; status: completed.
02
Drugs
ketamine
03
Conditions
Anesthesia
Beyond the preview
Go deeper on NCT03009409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03009409.